Trinity Biotech plc (TRIB)

Trinity Biotech Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1.55	5.17	3.69	6.58	25.91	27.33
Cash & Short-Term Investments	1.55	5.17	3.69	6.58	25.91	27.33
Cash Growth	-70.92%	39.99%	-43.89%	-74.61%	-5.18%	66.63%
Accounts Receivable	10.89	13.88	11.34	13.45	14.17	21.42
Other Receivables	0.43	0.73	1.67	2.21	1.54	3.18
Receivables	11.32	14.6	13.01	15.66	15.71	24.6
Inventory	20.13	19.37	19.93	22.5	29.12	30.22
Prepaid Expenses	-	1.98	2.04	1.93	1.95	1.16
Other Current Assets	-	-	0.37	-	-	-
Total Current Assets	33	41.12	39.04	46.67	72.69	83.3
Property, Plant & Equipment	4.31	4.62	1.89	5.68	5.92	8.55
Long-Term Investments	2.76	2.46	-	-	-	-
Goodwill	-	13.84	-	12.54	12.54	12.59
Other Intangible Assets	55.92	16.55	1.17	5.72	5.77	7.83
Long-Term Accounts Receivable	-	-	0.04	0.08	0.15	0.29
Long-Term Deferred Tax Assets	3.55	3.55	1.98	4.22	4.1	4.18
Long-Term Deferred Charges	-	20.95	15.1	17.01	17.68	13.44
Other Long-Term Assets	0.1	0.19	0.22	0.18	0.06	0.21
Total Assets	99.63	103.29	59.44	92.1	118.9	130.4
Accounts Payable	26.38	6.83	3.89	6.21	6.76	7.1
Accrued Expenses	-	14.37	8.07	9.06	8.12	9.69
Short-Term Debt	-	-	-	-	0.03	2.91
Current Portion of Long-Term Debt	0.21	0.21	0.21	0.21	83.31	-
Current Portion of Leases	2.3	2.29	1.69	1.68	1.98	2.15
Current Income Taxes Payable	0.47	0.36	0.28	0.03	0.02	0.15
Current Unearned Revenue	0.11	0.2	0.05	0.11	0.21	4.45
Other Current Liabilities	2.06	7.84	0.85	0.05	0.05	0.61
Total Current Liabilities	31.52	32.1	15.04	17.34	100.49	27.06
Long-Term Debt	99.5	87.79	54.65	58.05	-	82.7
Long-Term Leases	10.55	10.48	10.87	12.27	13.87	16.59
Long-Term Deferred Tax Liabilities	4.56	4.56	2.3	5.06	4.86	4.91
Other Long-Term Liabilities	3.03	3.55	0.53	1.57	-	1.37
Total Liabilities	149.17	138.47	83.38	94.28	119.21	132.62
Common Stock	4.34	4.19	1.97	1.96	1.21	1.21
Additional Paid-In Capital	63.8	63.4	46.62	46.46	16.19	16.19
Retained Earnings	-93.66	-79.12	-48.64	-26.7	12.56	10.57
Treasury Stock	-24.92	-24.92	-24.92	-24.92	-24.92	-24.92
Comprehensive Income & Other	0.91	1.27	1.03	1.02	-5.36	-5.27
Shareholders' Equity	-49.54	-35.18	-23.95	-2.18	-0.32	-2.22
Total Liabilities & Equity	99.63	103.29	59.44	92.1	118.9	130.4
Total Debt	112.56	100.76	67.43	72.2	99.19	104.34
Net Cash (Debt)	-111.01	-95.6	-63.74	-65.62	-73.28	-77.01
Net Cash Per Share	-4.91	-5.32	-8.33	-9.73	-17.53	-18.42
Filing Date Shares Outstanding	18.63	18.63	9.47	7.64	5.38	4.18
Total Common Shares Outstanding	18.63	17.96	7.67	7.62	4.18	4.18
Working Capital	1.48	9.03	24.01	29.33	-27.8	56.24
Book Value Per Share	-2.66	-1.96	-3.12	-0.29	-0.08	-0.53
Tangible Book Value	-105.46	-65.57	-25.12	-20.44	-18.62	-22.64
Tangible Book Value Per Share	-5.66	-3.65	-3.28	-2.68	-4.45	-5.41
Land	-	26.78	24.27	24.68	24.33	24.29
Machinery	-	41.03	39.04	38.22	36.54	38.15
Leasehold Improvements	-	2.81	2.76	2.7	2.59	2.67

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q